A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Body, Amy (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date1/05/24 → 30/04/29

Clinical Trial Phase

  • Phase I
  • Phase II